Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Xenon Pharmaceuticals disclosed equity inducement grants to 10 new non-officer employees. The grants consist of 32,750 share options and 19,200 restricted share units (RSUs), approved by the Compensation Committee.
Key figures
- New hires
- 10
- Rsus granted
- 19200
- Option exercise price
- 54.79
- Share options granted
- 32750
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.